US FDA to decide fate of Genentech's pertuzumab by 8 June
08 February 2012
Donna Young
Please Login to read the full article.
08 February 2012
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Roche's T-DM1 (Herceptin-plus) shows early benefit in first-line metastatic breast cancer
- EMILIA supports Roche's T-DM1 filing but MARIANNE will be key to market performance
- CLEOPATRA - Roche's pertuzumab to queen it over HER2 breast cancer?
- Bayer submits US, European applications for regorafenib in mCRC
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
